Pharmala Biotech Holdings Inc. (MDMA.CN)

CAD 0.17

(10.0%)

Total Debt Summary of Pharmala Biotech Holdings Inc.

  • Pharmala Biotech Holdings Inc.'s latest annual total debt in 2023 was 253.53 Thousand CAD , down 0.0% from previous year.
  • Pharmala Biotech Holdings Inc.'s latest quarterly total debt in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Pharmala Biotech Holdings Inc. reported annual total debt of - CAD in 2022, down 0.0% from previous year.
  • Pharmala Biotech Holdings Inc. reported annual total debt of - CAD in 2021, down 0.0% from previous year.
  • Pharmala Biotech Holdings Inc. reported quarterly total debt of - CAD for 2024 Q3, down 0.0% from previous quarter.
  • Pharmala Biotech Holdings Inc. reported quarterly total debt of - CAD for 2024 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Pharmala Biotech Holdings Inc. (2023 - 2021)

Historical Annual Total Debt of Pharmala Biotech Holdings Inc. (2023 - 2021)

Year Total Debt Total Debt Growth
2023 253.53 Thousand CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%

Peer Total Debt Comparison of Pharmala Biotech Holdings Inc.

Name Total Debt Total Debt Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 20 Thousand CAD -1167.685%
BetterLife Pharma Inc. 245.23 Thousand CAD -3.386%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. 3.87 Million CAD 93.457%
Rapid Dose Therapeutics Corp. 2.45 Million CAD 89.667%
Defence Therapeutics Inc. 1.74 Million CAD 85.483%
Entheon Biomedical Corp. - CAD -Infinity%
Gemina Laboratories Ltd. 285.32 Thousand CAD 11.141%
Glow Lifetech Corp. 116.18 Thousand CAD -118.22%
Lexston Life Sciences Corp. - CAD -Infinity%
Doseology Sciences Inc. - CAD -Infinity%
MYND Life Sciences Inc. 3 Million CAD 91.549%
Nova Mentis Life Science Corp. - CAD -Infinity%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. 3.83 Million CAD 93.387%
Telescope Innovations Corp. - CAD -Infinity%